FDA approves new, cheaper rival to EpiPen allergy shot

U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news